MedTrace Logo

Assessment of Device for Treatment of Amblyopia

NCT02003235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2017-07-21

No results posted yet for this study

Summary

The study will evaluate the effect of Reviview™, a dichoptic video display device for administrating a novel treatment protocol for Amblyopia (lazy eye) in kids.

The effect of the treatment will be measured by the change from baseline in Visual acuity and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients.

Conditions

  • Amblyopia

Interventions

DEVICE

Daily watching videos using Reviview™, a dichoptic video display device, for 60 min

Sponsors & Collaborators

  • Visior Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Haim Stolovitch, MD · Tel-Aviv Sourasky Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-07-15
Completion
2017-07-15

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003235 on ClinicalTrials.gov